Literature DB >> 35382239

Etiology unknown: Qualitative analysis of patient attributions of causality in scleroderma.

Shadi Gholizadeh1, Julia H Drizin2, Ingunn Hansdottir3, Michael H Weisman4, Philip J Clements5, Daniel E Furst5, Vanessa L Malcarne1,2.   

Abstract

Background: Questions about the etiology of disease can concern patients living with any chronic disease and may impact disease-related adjustment. These causal attributions may be of particular interest when individuals are living with diseases for which etiologies have not been definitively identified, such as scleroderma. This study qualitatively explored patient attributions of causality for scleroderma.
Methods: Patients with confirmed diagnoses of scleroderma responded to an open-ended prompt. The cross-sectional sample of scleroderma patients (N = 114) was recruited through registries maintained at the University of California, Los Angeles and University of California, San Diego Schools of Medicine and the Virginia Mason Medical Center. Content analysis was used to analyze the qualitative data and group the responses via an inductively derived codebook using the text analysis tool Dedoose Version 4.5.
Results: Patients provided a variety of possible causes for scleroderma, which grouped into seven themes: (1) stress, (2) environment, (3) genetics, (4) medical conditions or surgeries, (5) diet, (6) medications or substance use, and (7) spirituality.
Conclusion: Patients' causal attributions for scleroderma were varied, but many patients identified stress as a cause of scleroderma, often focusing on acute or chronic stressors that were present before disease onset. Identifying patient theories of causality for scleroderma can contribute to an increased understanding of disease-related behaviors and adjustment.
© The Author(s) 2018.

Entities:  

Keywords:  Causality; etiology; scleroderma; systemic scleroderma

Year:  2018        PMID: 35382239      PMCID: PMC8892868          DOI: 10.1177/2397198318761480

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  25 in total

1.  A meta-analytic review of coping with illness: do causal attributions matter?

Authors:  S C Roesch; B Weiner
Journal:  J Psychosom Res       Date:  2001-04       Impact factor: 3.006

Review 2.  Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.

Authors:  Jammie Barnes; Maureen D Mayes
Journal:  Curr Opin Rheumatol       Date:  2012-03       Impact factor: 5.006

3.  Illness attributions and the health belief model.

Authors:  J B King
Journal:  Health Educ Q       Date:  1983 Fall-Winter

4.  Patient-centred advice is effective in improving adherence to medicines.

Authors:  Sarah Clifford; Nick Barber; Rachel Elliott; Elaine Hartley; Rob Horne
Journal:  Pharm World Sci       Date:  2006-09-27

Review 5.  Rare diseases social epidemiology: analysis of inequalities.

Authors:  Anna Kole; François Faurisson
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Patients' and spouses' causal explanations of a myocardial infarction.

Authors:  E B Rudy
Journal:  Nurs Res       Date:  1980 Nov-Dec       Impact factor: 2.381

7.  Systemic sclerosis: patients' perceptions of their condition.

Authors:  Helen L Richards; Ariane L Herrick; Kerry Griffin; Petra D H Gwilliam; Jonathan Loukes; Dónal G Fortune
Journal:  Arthritis Rheum       Date:  2003-10-15

8.  Diabetes: the layperson's theories of causality.

Authors:  Francisco J Mercado-Martinez; Igor Martin Ramos-Herrera
Journal:  Qual Health Res       Date:  2002-07

Review 9.  Life with a rare chronic disease: the scleroderma experience.

Authors:  Gloria Joachim; Sonia Acorn
Journal:  J Adv Nurs       Date:  2003-06       Impact factor: 3.187

10.  Trait anxiety, symptom perceptions, and illness-related responses among women with breast cancer in remission during a tamoxifen clinical trial.

Authors:  L D Cameron; H Leventhal; R R Love
Journal:  Health Psychol       Date:  1998-09       Impact factor: 4.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.